Effects of a novel curcumin derivative on insulin synthesis and secretion in streptozotocin-treated rat pancreatic islets in vitro

Chinese Medicine (United Kingdom)

Volumn 9, Issue 1, 2014, Pages

  Aziz, Mohammed Talaat A ^a   El Asmar, Mohammed F ^b   Rezq, Ameen M ^a   Wassef, Mohammed Abdel A ^a   Fouad, Hanan ^a   Roshdy, Nagwa K ^a   Ahmed, Hanan H ^a   Rashed, Laila A ^a   Sabry, Dina ^a   Taha, Fatma M ^a   Hassouna, Amira ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CALCIUM; CURCUMIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE TRANSPORTER 2; HEME OXYGENASE 1; INSULIN; MESSENGER RNA; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR PDX 1; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CULTURE MEDIUM; DNA DAMAGE; DNA FRAGMENTATION ASSAY; DRUG EFFECT; FEMALE; GENE OVEREXPRESSION; IN VITRO STUDY; INSULIN RELEASE; INSULIN SYNTHESIS; NONHUMAN; PANCREAS ISLET CELL; PROTEIN PHOSPHORYLATION; RAT;

EID: 84892522805     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/1749-8546-9-3     Document Type: Article

References (55)

1. Meghana K, Sanjeev G, Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur J Pharmacol 2007, 577:183-191. 10.1016/j.ejphar.2007.09.002, 17900558.
2. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994, 76:1025-1037. 10.1016/0092-8674(94)90380-8, 8137421.
3. Kyriakis JM, Banerjee P, Nikolakaki E, Dai T, Rubie EA, Ahmad MF, Avruch J, Woodgett JR. The stress activated protein kinase subfamily of c-Jun kinases. Nature 1994, 369:156-160. 10.1038/369156a0, 8177321.
4. Kyriakis JM, Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 1996, 18:567-577. 10.1002/bies.950180708, 8757935.
5. Anderson P. Kinase cascades regulating entry into apoptosis. Microbiol Mol Biol Rev 1997, 61:33-46. 232599, 9106363.
6. Watada H, Kajimoto Y, Umayahara Y, Matsuoka T, Kaneto H, Fujitani Y, Kamada T, Kawamori R, Yamasaki Y. The human glucokinase geneβcell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells. Diabetes 1996, 45:1478-1488. 10.2337/diab.45.11.1478, 8866550.
7. Edlund H. Transcribing pancreas. Diabetes 1998, 47:1817-1823. 10.2337/diabetes.47.12.1817, 9836511.
8. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996, 122:983-995.
9. Sander M, German MS. The beta cell transcription factors and development of the pancreas. J Mol Med 1997, 75:327-340. 10.1007/s001090050118, 9181474.
10. Habener JF, Stoffers DA. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Assoc Am Physicians 1998, 110:12-21.
11. Waeber G, Thompson N, Nicod P, Bonny C. Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996, 10:1327-1334.
12. Kanitkar M, Galande S, Bhonde R. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals:a prophylactic and protective role. Eur J Pharmacol 2007, 577:183-191. 10.1016/j.ejphar.2007.09.002, 17900558.
13. Kanitkar M, Gokhale K, Galande S, Bhonde R. Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo. Br J Pharmacol 2008, 155:702-713. 2584917, 18695642.
14. Chen YR, Tan TH. Inhibition of the c-Jun N-terminal kinase [JNK] signaling pathway by curcumin. Oncogene 1998, 17(2):173-178. 10.1038/sj.onc.1201941, 9674701.
15. Daval M, Bedrood S, Gurlo T, Huang CJ, Costes S, Butler PC, Langen R. The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid 2010, 17(3-4):118-128.
16. Rezende LF, Vieira AS, Negro A, Langone F, Boschero AC. Ciliary neurotrophic factor (CNTF) signals through STAT3-SOCS3 pathway and protects rat pancreatic islets from cytokine-induced apoptosis. Cytokine 2009, 46(1):65-71. 10.1016/j.cyto.2008.12.014, 19272793.
17. Balamurugan AN, Akhov L, Selvaraj G, Pugazhenthi S. Induction of antioxidant enzymes by curcumin and its analogues in human islets: implications in transplantation. Pancreas 2009, 38(4):454-460. 10.1097/MPA.0b013e318196c3e7, 19188863.
18. Abdel Aziz MT, El-Asmar MF, El Nadi EG, Wassef MA, Ahmed HH, Rashed LA, Obaia EM, Sabry D, Hassouna AA, Abdel Aziz AT. The effect of curcumin on insulin release in rat-isolated pancreatic islets. Angiology 2010, 61(6):557-566. 10.1177/0003319709356424, 20395228.
19. Abdel Aziz MT, El-Asmar MF, El-Ibrashy IN, Rezq AM, Al-Malki AL, Wassef MA, Fouad HH, Ahmed HH, Taha FM, Hassouna AA, Morsi HM. Effect of novel water soluble curcumin derivative on experimental type- 1 diabetes mellitus (short term study). Diabetol Metab Syndr 2012, 4(1):30. [Epub ahead of print], 10.1186/1758-5996-4-30, 3533893, 22762693.
20. Cai K, Qi D, Hou X, Wang O, Chen J, Deng B, Qian L, Liu X, Le Y. MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2. PLoS One 2011, 6(5):e19559. 10.1371/journal.pone.0019559, 3092759, 21589925.
21. Khalooghi K, Hashemi S, Mehraban N, Amiri P, Bazzaz JT, Larijani B, Amoli MM. In vitro modulation of TCF7L2 gene expression in human pancreatic cells. Mol Biol Rep 2009, 36(8):2329-2332. 10.1007/s11033-009-9452-3, 19156536.
22. Abdel Aziz MT, Motawi T, Rezq A, Mostafa T, Fouad HH, Ahmed HH, Rashed L, Sabry D, Senbel A, Al-Malki A, El-Shafiey R. Effects of a water-soluble curcumin protein conjugate vs. Pure curcumin in a diabetic model of erectile dysfunction. J Sex Med 2012, 9(7):1815-1833. 10.1111/j.1743-6109.2012.02741.x, 22548787.
23. Rezq AM, Abdel Aziz MT, Al-Malki AL. Gelatin, a novel curcumin drug carrier system, WO/2011/100984. World Intellect Prop Org (WIPO) http://patentscope.wipo.int/search/en/detail.jsf%3Bjsessionid+90C05C7570FE02B89EBE9013FC25D794.wapp1?docId=WO2011100984&recNum=72&office=&queryString=&prevFilter=&sortOption=Pub+Date+Desc&maxRec=8021524.
24. Shewade YM, Umrani M, Bhonde R. Large-scale isolation of islets by tissue culture of adult mouse pancreas. Transplant Proc 1999, 31:1721-1723. 10.1016/S0041-1345(99)00077-9, 10331051.
25. Keong Tan K, Hwi Kim K. Alternanthera sessilis red ethyl acetate fraction exhibits antidiabetic potential on obese type 2 diabetic rats. Evid Base Com Altern Med 2013, 2013:845172.
26. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989, 337:181-184. 10.1038/337181a0, 2521375.
27. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm 2007, 4:807-418. 10.1021/mp700113r, 17999464.
28. Johansson EB, Tjalve H. Studies on the tissue-deposition and fate of [14C]-streptozotocin with special reference to the pancreatic islets. Acta Endocrinol 1969, 89:339-347.
29. Okamoto H. Molecular basis of experimental diabetes: degeneration, oncogenesis and regeneration of pancreatic b-cells of islet of Langerhans. Bioassays 1985, 2:15-21.
30. Chanpoo M, Petchpiboonthai H, Panyarachun B, Anupunpisit V. Effect of curcumin in the amelioration of pancreatic islets in streptozotocin induced diabetic mice. J Med Assoc Thai 2010, 93:S152-S159.
31. Kanitkar M, Bhonde R. Curcumin treatment enhances islet recovery by induction of heat shock response proteins, Hsp70 and heme-oxygenase-1, during cryopreservation. Life Sci 2008, 82:182-189. 10.1016/j.lfs.2007.10.026, 18093618.
32. Weiss L, Whitmarsh AJ, Yang DD, Rincon M, Davis RJ, Flavell RA. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation. J Exp Med 2000, 191:139-146. 10.1084/jem.191.1.139, 2195805, 10620612.
33. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000, 408:239-247. 10.1038/35041687, 11089981.
34. Liu W, Schoenkerman A, Lowe WLJR. Activation of members of the mitogen-activated protein kinase family by glucose in endothelial cells. Am J Physiol Endocrinol Metab 2000, 279(4):E782-E790.
35. Purves T, Middlemas A, Agthong S, Jude EB, Boulton AJ, Fernyhough P, Tomlinson DR. A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 2001, 15:2508-2514. 10.1096/fj.01-0253hyp, 11689477.
36. Kaneto H, Xu G, Fujii N, Kim S, Weir S, Weir G. Involvement of c-Jun N-terminal Kinase in Oxidative Stress-mediated Suppression of Insulin Gene Expression. J Biol Chem 2002, 277(33):30010-30018. 10.1074/jbc.M202066200, 12011047.
37. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka T. Involvement of Oxidative Stress and the JNK Pathway in Glucose Toxicity. Rev Diabet Stud 2004, 1(4):165-174. 10.1900/RDS.2004.1.165, 1783693, 17491701.
38. Kawamori D, Kajimoto Y, Kaneto H, Umayahara Y, Fujitani Y, Miyatsuka T, Watada H, Leibiger IB, Yamasaki Y, Hori M. Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH2-terminal kinase. Diabetes 2003, 52:2896-2904. 10.2337/diabetes.52.12.2896, 14633849.
39. Marshak S, Benshushan E, Shoshkes M, Havin L, Cerasi E, Melloul D. Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3beta transcription factors mediate betacell- specific expression. Mol Cell Biol 2000, 20:7583-7590. 10.1128/MCB.20.20.7583-7590.2000, 86312, 11003654.
40. Peshavaria M, Henderson E, Sharma A, Wright CV, Stein R. Functional characterization of the transactivation properties of the PDX-1 homeodomain protein. Mol Cell Biol 1997, 17:3987-3996. 232251, 9199333.
41. Shu L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J, Maedler K. Transcription factor 7-like 2 regulates beta-cell survival and function in human pancreatic islets. Diabetes 2008, 57:645-653. 10.2337/db07-0847, 18071026.
42. Yi F, Brubaker PL, Jin T. TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J Biol Chem 2005, 280:1457-1464.
43. Saxena R, Gianniny L, Burtt NP, Lyssenko V, Giuducci C, Sjögren M, Florez JC, Almgren P, Isomaa B, Orho-Melander M, Lindblad U, Daly MJ, Tuomi T, Hirschhorn JN, Ardlie KG, Groop LC, Altshuler D. Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 2006, 55:2890-2895. 10.2337/db06-0381, 17003358.
44. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, Mitchell BD, Shuldiner AR. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 2006, 55:2654-2659. 10.2337/db06-0338, 16936218.
45. da Silva XG, Loder MK, McDonald A, Tarasov AI, Carzaniga R, Kronenberger K, Barg S, Rutter GA. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells. Diabetes 2009, 58(4):894-905. 10.2337/db08-1187, 2661588, 19168596.
46. Lang J. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur J Biochem 1999, 259:3-17. 10.1046/j.1432-1327.1999.00043.x, 9914469.
47. Malhotra A, Nair P, Dhawan DK. Curcumin and resveratrol synergistically stimulate p21 and regulate cox-2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Cancer Prev 2011, 20(5):411-416. 10.1097/CEJ.0b013e3283481d71, 21633290.
48. Kalpana C, Menon VP. Protective effect of curcumin on circulatory lipid peroxidation and antioxidant status during nicotine-induced toxicity. Toxicol Mech Methods 2004, 14(6):339-343. 10.1080/15376520490434692, 20021100.
49. Li YV. Zinc and insulin in pancreatic beta-cells. Endocrine 2013, Aug 24. [Epub ahead of print].
50. Istyastono EP. Docking studies of curcumin as a potential lead compound to develop novel dipeptydyl peptidase-4 inhibitors. Indo J Chem 2009, 9(1):132-136.
51. Ahrén B. Dipeptidyl peptidase-4 inhibitors: clinical data and clinical implications. Diabetes Care 2007, 30(6):1344-1350. 10.2337/dc07-0233, 17337494.
52. Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012, 35(11):2121-2127. 10.2337/dc12-0116, 3476912, 22773702.
53. Best L, Elliott AC, Brown PD. Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel. Biochem Pharmacol 2007, 73:1768-1775. 10.1016/j.bcp.2007.02.006, 17382910.
54. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009, 41(1):40-59. 10.1016/j.biocel.2008.06.010, 2637808, 18662800.
55. Chang CL, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Alternat Med 2013, 2013:378657. Epub 2013 Apr 4, 3638592, 23662132.